Cite this article
25
Downloads
41
Citations
27
Views
Announcements
Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
Article
Current vaccine adjuvants: an overview of a diverse class
Show Less
1
Antigenics, Inc., 3 Forbes Road, Lexington, MA 02421
Academic Editor:Narendra Chirmule
Front. Biosci. (Landmark Ed) 2004, 9(5), 2972–2988;
https://doi.org/10.2741/1452
Published: 1 September 2004
(This article belongs to the Special Issue Molecular aspects to vaccine design molecular aspects to vaccine design)
Abstract
Numerous compounds are under evaluation as immunological adjuvants for improvement of vaccine performance. This review will briefly summarize some of the many diverse substances that are currently being utilized as vaccine adjuvants in preclinical and clinical studies.